The idea to question
A starting price describes every future fill.
The short answer
A government-listed offer for semaglutide (Ozempic), as of September 2026, gives new self-pay patients their first two monthly fills for $199 each. The eligible strengths are 0.5 mg and 0.25 mg. These are price conditions, not advice on which strength to take. The government-listed cash offer
Keep the later price in view
After those first two fills, the September 2026 monthly price is $349 at the 1 mg strength. It is also $349 at 0.25 mg and at 0.5 mg. For the 2 mg strength, the listed price is $499 a month. The government-listed cash offer
Those introductory terms reach their end on December 31, 2026. Check whether they apply to the prescription being discussed. The government-listed cash offer
The offer also requires adult US residency. Its terms exclude asking insurance to reimburse the purchase or count it toward a deductible. The government-listed cash offer
Your deductible is the amount due from you before certain insurance benefits kick in. Ask the plan how a cash purchase would be treated.
Read the price as a set of conditions
- Is this the first-fill price or the ongoing price?
- Which prescribed product and strength does it cover?
- What date do these terms end?
- Will other care charges be added?
Keep the written terms with the quote. If the comparison still feels unclear, ask for a total for the actual plan being offered.